|
| 37000774 | Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres. | | 2023 |
| 37580184 | Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients. | | 2023 |
| 37090558 | Identification of differentially recognized T cell epitopes in the spectrum of Mtb infection. | bioRxiv | 2023 |
| 36757183 | Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort. | | 2023 |
| 36752055 | Designing molecular diagnostics for current tuberculosis drug regimens. | | 2023 |
| 35252594 | Detecting rifampin and isoniazid resistance in direct from patient sputum using an automated integrated system. | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases | 2022 |
| 35907429 | Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study. | Lancet Microbe, The | 2022 |
| 35758754 | Variants in Bedaquiline-Candidate-Resistance Genes: Prevalence in Bedaquiline-Naive Patients, Effect on MIC, and Association with Mycobacterium tuberculosis Lineage. | Antimicrob Agents Chemother | 2022 |
| 35996278 | Contributions of GeneXpert to TB diagnosis in Myanmar. | International Journal of Tuberculosis and Lung Disease | 2022 |
| 35925649 | Knowledge, Attitude, Practices, and Vaccine Hesitancy Among the Latinx Community in Southern California Early in the COVID-19 Pandemic: Cross-sectional Survey. | JMIR Form Res | 2022 |
| 36962566 | Prevalence of SARS-CoV-2 infection in Baja California, Mexico: Findings from a community-based survey in February 2021 in the Mexico-United States border. | PLOS Glob Public Health | 2022 |
| 36466831 | Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease. | Frontiers in Immunology | 2022 |
| 34584117 | Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease. | Scientific Reports | 2021 |
| 34259165 | Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study. | JMIR Research Protocols | 2021 |
| 33406051 | Assessing COVID-19-Related Knowledge, Attitudes, and Practices Among Hispanic Primary Care Patients: Protocol for a Cross-sectional Survey Study. | JMIR Research Protocols | 2021 |
| 34555657 | Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease. | Tuberculosis (Edinb) | 2021 |
| 34372793 | Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF. | BMC Infectious Diseases | 2021 |
| 32727827 | Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples. | Journal of Clinical Microbiology | 2020 |
| 32081980 | Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase. | Scientific Reports | 2020 |
| 31959145 | Requiring smartphone ownership for mHealth interventions: who could be left out? | BMC Public Health | 2020 |
| 32817085 | Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance. | Journal of Clinical Microbiology | 2020 |
| 32623232 | Review of automated DNA extraction systems for sequencing-based solutions for drug-resistant tuberculosis detection. | Diagnostic Microbiology and Infectious Disease | 2020 |
| 30883637 | Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex. | Clinical Infectious Diseases | 2019 |
| 31593599 | Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests. | Journal of Infectious Diseases | 2019 |
| 31039166 | Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation. | PLoS Medicine | 2019 |
| 31085512 | Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment Response. | Antimicrobial Agents and Chemotherapy | 2019 |
| 31209399 | Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. | Nature Reviews Microbiology | 2019 |
| 27748157 | Surveillance or support: The experience of direct observation during tuberculosis treatment. | Glob Public Health | 2018 |
| 30596645 | Enabling precision medicine via standard communication of HTS provenance, analysis, and results. | PLoS Biol | 2018 |
| 30337678 | Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase. | Scientific Reports | 2018 |
| 30280646 | Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. | N Engl J Med | 2018 |
| 29499645 | Cost analysis of rapid diagnostics for drug-resistant tuberculosis. | BMC Infect Dis | 2018 |
| 29846561 | Mycobacterial biomaterials and resources for researchers. | Pathogens and Disease | 2018 |
| 29284687 | A standardised method for interpreting the association between mutations and phenotypic drug resistance in . | European Respiratory Journal | 2017 |
| 29016684 | Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting. | PLoS ONE | 2017 |
| 28381434 | Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for <i>Mycobacterium tuberculosis</i>. | Eur Respir J | 2017 |
| 28630430 | A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis. | Scientific Reports | 2017 |
| 28404672 | Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs. | J Clin Microbiol | 2017 |
| 28475735 | Impact of Fluoroquinolone Use on Mortality Among a Cohort of Patients With Suspected Drug-Resistant Tuberculosis. | Clin Infect Dis | 2017 |
| 28043592 | Next-generation sequencing-based user-friendly platforms for drug-resistant tuberculosis diagnosis: A promise for the near future. | International Journal of Mycobacteriology | 2016 |
| 26927983 | Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. | International Journal of Mycobacteriology | 2016 |
| 26792466 | Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in India. | International Journal of Tuberculosis and Lung Disease | 2016 |
| 26792465 | Redefining MTBDRplus test results: what do indeterminate results actually mean? | International Journal of Tuberculosis and Lung Disease | 2016 |
| 27225403 | Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study. | Journal of Clinical Microbiology | 2016 |
| 27090176 | Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape. | Antimicrob Agents Chemother | 2016 |
| 27084817 | A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis. | Int J Tuberc Lung Dis | 2016 |
| 27036978 | Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex. | Diagnostic Microbiology and Infectious Disease | 2016 |
| 27486746 | Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review. | PLoS ONE | 2016 |
| 26763971 | MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis. | J Clin Microbiol | 2016 |
| 27576542 | Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis. | BMC Infect Dis | 2016 |